Vaxart Total Current Liabilities vs Total Assets Analysis

VXRT Stock  USD 0.60  0.01  1.64%   
Vaxart financial indicator trend analysis is much more than just breaking down Vaxart Inc prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Vaxart Inc is a good investment. Please check the relationship between Vaxart Total Current Liabilities and its Total Assets accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vaxart Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Total Current Liabilities vs Total Assets

Total Current Liabilities vs Total Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Vaxart Inc Total Current Liabilities account and Total Assets. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Vaxart's Total Current Liabilities and Total Assets is 0.45. Overlapping area represents the amount of variation of Total Current Liabilities that can explain the historical movement of Total Assets in the same time period over historical financial statements of Vaxart Inc, assuming nothing else is changed. The correlation between historical values of Vaxart's Total Current Liabilities and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Liabilities of Vaxart Inc are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Total Current Liabilities i.e., Vaxart's Total Current Liabilities and Total Assets go up and down completely randomly.

Correlation Coefficient

0.45
Relationship DirectionPositive 
Relationship StrengthWeak

Total Current Liabilities

Total Current Liabilities is an item on Vaxart balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Vaxart Inc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Assets

Total assets refers to the total amount of Vaxart assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Vaxart Inc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.
Most indicators from Vaxart's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Vaxart Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vaxart Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Enterprise Value is likely to gain to about 127.8 M in 2024, whereas Selling General Administrative is likely to drop slightly above 21.2 M in 2024.
 2021 2022 2023 2024 (projected)
Total Operating Expenses70.6M110.4M90.7M95.3M
Cost Of Revenue48.7M3.3M68.1M53.4M

Vaxart fundamental ratios Correlations

0.210.290.450.980.57-0.64-0.530.820.680.390.9-0.10.70.42-0.180.80.730.650.480.850.270.090.04-0.57-0.41
0.21-0.070.010.10.60.35-0.69-0.170.470.52-0.01-0.420.610.460.030.40.610.450.58-0.110.56-0.07-0.2-0.44-0.35
0.29-0.070.790.30.06-0.240.020.260.07-0.140.230.620.03-0.3-0.110.040.10.130.020.29-0.04-0.25-0.24-0.080.04
0.450.010.790.430.37-0.19-0.20.280.310.060.280.620.28-0.24-0.140.320.230.30.270.330.14-0.20.22-0.31-0.23
0.980.10.30.430.47-0.73-0.370.870.610.320.93-0.010.60.26-0.150.740.60.480.40.910.110.070.12-0.54-0.36
0.570.60.060.370.470.16-0.850.090.90.820.26-0.310.920.490.210.720.850.680.870.190.720.070.02-0.74-0.66
-0.640.35-0.24-0.19-0.730.16-0.13-0.950.00.28-0.88-0.130.0-0.040.34-0.24-0.09-0.140.12-0.910.34-0.01-0.10.01-0.13
-0.53-0.690.02-0.2-0.37-0.85-0.13-0.13-0.73-0.6-0.260.4-0.85-0.750.13-0.63-0.95-0.84-0.83-0.15-0.83-0.010.250.510.44
0.82-0.170.260.280.870.09-0.95-0.130.24-0.10.950.040.280.21-0.330.470.350.360.130.94-0.070.040.07-0.22-0.05
0.680.470.070.310.610.90.0-0.730.240.760.38-0.320.920.50.090.760.830.660.80.310.610.41-0.1-0.82-0.83
0.390.52-0.140.060.320.820.28-0.6-0.10.760.16-0.520.710.480.520.540.630.510.50.10.410.20.0-0.6-0.58
0.9-0.010.230.280.930.26-0.88-0.260.950.380.16-0.080.40.32-0.220.590.480.470.180.98-0.060.00.08-0.3-0.11
-0.1-0.420.620.62-0.01-0.31-0.130.40.04-0.32-0.52-0.08-0.41-0.77-0.25-0.33-0.41-0.43-0.250.05-0.34-0.390.240.270.3
0.70.610.030.280.60.920.0-0.850.280.920.710.4-0.410.580.050.810.920.720.890.290.780.25-0.11-0.81-0.75
0.420.46-0.3-0.240.260.49-0.04-0.750.210.50.480.32-0.770.58-0.090.460.750.860.420.180.560.28-0.41-0.26-0.27
-0.180.03-0.11-0.14-0.150.210.340.13-0.330.090.52-0.22-0.250.05-0.09-0.1-0.1-0.16-0.05-0.210.01-0.10.21-0.1-0.03
0.80.40.040.320.740.72-0.24-0.630.470.760.540.59-0.330.810.46-0.10.730.620.660.490.480.140.15-0.76-0.61
0.730.610.10.230.60.85-0.09-0.950.350.830.630.48-0.410.920.75-0.10.730.860.810.370.750.11-0.32-0.6-0.51
0.650.450.130.30.480.68-0.14-0.840.360.660.510.47-0.430.720.86-0.160.620.860.560.350.620.17-0.28-0.41-0.38
0.480.580.020.270.40.870.12-0.830.130.80.50.18-0.250.890.42-0.050.660.810.560.110.840.09-0.08-0.7-0.63
0.85-0.110.290.330.910.19-0.91-0.150.940.310.10.980.050.290.18-0.210.490.370.350.11-0.19-0.050.14-0.24-0.04
0.270.56-0.040.140.110.720.34-0.83-0.070.610.41-0.06-0.340.780.560.010.480.750.620.84-0.190.11-0.25-0.56-0.49
0.09-0.07-0.25-0.20.070.07-0.01-0.010.040.410.20.0-0.390.250.28-0.10.140.110.170.09-0.050.11-0.27-0.41-0.7
0.04-0.2-0.240.220.120.02-0.10.250.07-0.10.00.080.24-0.11-0.410.210.15-0.32-0.28-0.080.14-0.25-0.27-0.070.04
-0.57-0.44-0.08-0.31-0.54-0.740.010.51-0.22-0.82-0.6-0.30.27-0.81-0.26-0.1-0.76-0.6-0.41-0.7-0.24-0.56-0.41-0.070.82
-0.41-0.350.04-0.23-0.36-0.66-0.130.44-0.05-0.83-0.58-0.110.3-0.75-0.27-0.03-0.61-0.51-0.38-0.63-0.04-0.49-0.70.040.82
Click cells to compare fundamentals

Vaxart Account Relationship Matchups

Vaxart fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets37.0M152.6M221.2M153.8M91.8M150.6M
Short Long Term Debt Total2.3M7.2M13.0M21.7M26.5M29.3M
Other Current Liab2.9M7.6M5.9M8.2M5.6M9.8M
Total Current Liabilities9.2M11.8M10.8M17.9M13.7M17.6M
Total Stockholder Equity13.0M123.4M187.5M110.6M57.8M89.3M
Property Plant And Equipment Net2.2M8.3M19.8M41.3M36.6M27.5M
Net Debt(11.2M)(119.7M)(130.7M)(22.3M)(8.2M)(8.7M)
Retained Earnings(116.7M)(148.9M)(219.4M)(327.1M)(409.6M)(389.1M)
Cash13.5M126.9M143.7M44.0M34.8M52.2M
Non Current Assets Total19.4M24.1M52.0M54.4M46.3M40.4M
Non Currrent Assets Other141K372K890K3.6M926K879.7K
Cash And Short Term Investments13.5M126.9M166.5M93.7M39.7M61.2M
Net Receivables3.6M334K71K20K3.0M2.9M
Common Stock Shares Outstanding21.6M88.3M121.5M127.7M144.8M152.1M
Liabilities And Stockholders Equity37.0M152.6M221.2M153.8M91.8M150.6M
Non Current Liabilities Total14.9M17.4M22.9M25.3M20.3M27.5M
Other Current Assets453K2.4M5.2M3.7M2.8M4.7M
Other Stockholder Equity129.6M272.3M406.9M438.0M467.4M490.7M
Total Liab24.1M29.2M33.6M43.3M34.0M44.6M
Property Plant And Equipment Gross2.2M8.3M19.8M15.6M43.4M24.7M
Total Current Assets17.6M128.5M169.2M99.5M45.5M43.3M
Accumulated Other Comprehensive Income(1.6M)(459K)(74K)(299K)(1K)(1.1K)
Short Term Debt841K2.1M1.0M2.3M6.5M6.8M
Intangible Assets17.1M15.4M10.6M5.0M4.3M4.1M
Accounts Payable852K2.1M3.9M5.5M1.6M1.5M
Common Stock Total Equity714K4.8M11K13K11.7K11.1K
Common Stock714K5K11K13K15K14.3K
Current Deferred Revenue4.6M4.2M5.1M2M(1.1M)(1.0M)
Other Liab13.4M14.9M10.9M5.9M6.7M7.9M
Net Tangible Assets13.0M123.4M187.5M110.6M127.2M67.4M
Other Assets141K372K890K3.6M4.1M4.3M
Retained Earnings Total Equity(116.7M)(148.9M)(219.4M)(327.1M)(294.4M)(279.7M)
Capital Surpluse124.8M272.3M406.9M438.0M503.7M528.9M
Property Plant Equipment210K1.5M6.6M15.6M17.9M18.8M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Vaxart Stock Analysis

When running Vaxart's price analysis, check to measure Vaxart's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxart is operating at the current time. Most of Vaxart's value examination focuses on studying past and present price action to predict the probability of Vaxart's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxart's price. Additionally, you may evaluate how the addition of Vaxart to your portfolios can decrease your overall portfolio volatility.